| 000 | 00961nam a2200265Ia 4500 | ||
|---|---|---|---|
| 001 | 11160 | ||
| 003 | BIBL | ||
| 005 | 20160527183224.0 | ||
| 008 | 730206s1972 mdua b 00010 eng | ||
| 010 | _a 72603271 //r852 | ||
| 041 | 0 | _aspa | |
| 049 |
_aEVLG _b615.788 _bU586 _bNIMH:p2 _cc1 |
||
| 050 | 0 |
_aRM315 _b.U77 1972 |
|
| 082 | _a615/.788 | ||
| 092 |
_a615.788 _bU586 _bNIMH:p2 |
||
| 110 | 1 | 0 |
_aU.S. National Institute of Mental Health. _9285523 _2Local |
| 245 | 1 | 0 |
_aPsychotropic drugs and related compounds _cEarl Usdin and Daniel H. Efron. |
| 250 | _a2d ed. | ||
| 260 | 0 |
_aRockville, Md. _bNational Institute of Mental Health; [for sale by the Supt. of Docs., U.S. Govt. Print. Off., Washington _c1972] |
|
| 300 |
_avi, 791 p. _billus. |
||
| 504 | _aBibliography: p. 605-657. | ||
| 650 | 0 |
_aPsychotropic drugs _9154835 _2Local |
|
| 700 | 1 | 0 |
_aEfron, Daniel H. _ejoint author. _9219827 _2Local |
| 710 | 2 | 0 |
_aNational Institute of Mental Health U.S. _9141353 _2Local |
| 999 |
_c8522 _d8522 |
||